RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Idiopathic Hypersomnia: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Post-Nap Sleep Inertia in Narcolepsy Type 1 and Idiopathic Hypersomnia.
Derre Alexandre et al., Sleep (8 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42847892/
- 2.
Narcolepsy and Idiopathic Hypersomnia Real-World Treatment Patterns and Changes in Alerting Agent Use After Low-Sodium Oxybate Initiation: A Retrospective Claims Analysis.
Markt Sarah C et al., Neurology and therapy (6 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42839216/
- 3.
Sex- and gender-related differences in narcolepsy and idiopathic hypersomnia: a narrative review
Ji Soo Chung et al., Sleep Medicine Reviews (1 October 2026)
https://doi.org/10.1016/j.smrv.2026.102386
- 4.
Diagnostic Value of Psychomotor Vigilance Task for Severe Sleep Inertia in Idiopathic Hypersomnia Versus Other Sleep Disorders Without Sleep Inertia.
Evangelista Elisa et al., Journal of sleep research (1 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42219783/
- 5.
Complex post-traumatic stress disorder in patients initially diagnosed with idiopathic hypersomnia: a case series
Vlad Bucurescu et al., Journal of Behavioral and Cognitive Therapy (17 September 2026)
https://doi.org/10.1016/j.jbct.2026.100638
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
NCT07646678 · Recruiting · Phase 2 / Phase 3 · Takeda
Ages 18 to 71
https://clinicaltrials.gov/study/NCT07646678
- 2.
A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia
NCT07006233 · Recruiting · University of Sydney
Ages 18 and over
https://clinicaltrials.gov/study/NCT07006233
- 3.
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683 · Recruiting · Phase 2 / Phase 3 · Alkermes, Inc.
Ages 18 to 70
https://clinicaltrials.gov/study/NCT06767683
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Idiopathic Hypersomnia
Idiopathic hypersomnia is a long-term sleep disorder in which people are excessively sleepy during the day despite a normal or long night's sleep. Waking up can be extremely hard, and naps are usually not refreshing. It is managed with medicines that promote wakefulness, including some that were first developed for narcolepsy.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
STUDY OBJECTIVES: To compare post-nap sleep inertia between patients with idiopathic hypersomnia (IH) and narcolepsy type 1 (NT1) by assessing changes in subjective sleepiness and objective performance. METHODS: In 128 drug-free patients (50 IH, 78 NT1), standardized overnight polysomnography and Multiple Sleep Latency Testing were performed, with 5-minute Psychomotor Vigilance Task (PVT) and Karolinska Sleepiness Scale (KSS) assessments immediately before and after the 11:00 AM MSLT nap. Sleep inertia was defined as pre- to post-nap changes. Associations with clinical and polysomnographic variables were examined. RESULTS: NT1 and IH differed in nap duration and sleep architecture, with greater REM sleep in NT1 and longer N2 sleep in IH. Despite these differences, both groups exhibited comparable post-nap increases in KSS and in PVT lapses, with higher absolute KSS values in IH but no between-group differences in the magnitude of change. Post-nap KSS showed a modest correlation with post-nap PVT lapses, whereas no association was observed in the pre-nap condition. Post-nap subjective impairment was related to baseline KSS and IH severity scores, while post-nap performance impairment was primarily driven by pre-nap lapse count. No nap sleep-stage variables independently accounted for performance outcomes. MSLT-derived features showed weak and inconsistent associations with subjective outcomes and no association with performance in IH and NT1. CONCLUSIONS: Sleep inertia immediately after a short morning nap is a reproducible phenomenon in IH and NT1, largely independent of nap sleep architecture. Post-nap impairment mainly reflects underlying sleepiness and performance deficits, supporting a shared mechanism of sleep inertia across central hypersomnolence disorders.
Common Questions
What is Idiopathic Hypersomnia?
Idiopathic hypersomnia is a long-term sleep disorder in which people are excessively sleepy during the day despite a normal or long night's sleep. Waking up can be extremely hard, and naps are usually not refreshing. It is managed with medicines that promote wakefulness, including some that were first developed for narcolepsy.
How many clinical trials are available for Idiopathic Hypersomnia?
RareWays currently indexes 37 clinical trials for Idiopathic Hypersomnia, of which 13 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Idiopathic Hypersomnia come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Idiopathic Hypersomnia.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.